Mumbai, 17th January 2022: A.Menarini India Private Limited (“Menarini India”), part of the Menarini Group, the world’s largest Italian biopharmaceutical company, has announced the appointment of Mr. Girisan Kariangal as the new Managing Director of India with effect from
1 January 2022 as part of its continuing leadership succession plan. Girisan replaces Mr. Anandh Balasundaram who will be retiring from the Company within the next few months, after 7 successful and transformative years at the helm of Menarini India. Girisan has been with Menarini India since 2010 and in aggregate, has over 30 years of pharmaceutical leadership experience, covering a broad spectrum of commercial and support functions. During his tenure at Menarini India, among other things, he has played an integral role in transforming the company from a CSO led business to a strong branded formulations company.
Menarini India also announced its market expansion plans in India with the launch of a new product line-up. With this move, Menarini aims to strengthen its Dermatology portfolio in India that will offer international innovative solutions for overall skin health.
Menarini India will be launching Menarini’s global Relife portfolio in both Aesthetics and Dermatology (Cosmetic and Medical) areas. In addition, Menarini India will seek to expand its product range by collaborating with leading formulation vendors to launch line extensions and improve the current formulations, and collaborating with leading dermatology companies to launch innovative products in India. To widen the reach of their cosmetic portfolio, Menarini India is well positioned to leverage the digital and e-commerce platforms with direct-to-consumer plans in the pipeline.
Recently, Menarini India launched DefinisseTM double needle threads, a revolutionary solution in the minimally invasive aesthetic procedures for face-lift. Menarini India will continue its focus on expanding the DefinisseTM threads portfolio with upcoming launch of Free Floating DefinisseTM threads, DefinisseTM Fillers, and skincare products – sunscreen with a novel patented technology, hair serum with unique proven ingredients and an acne scar serum specially formulated for the Indian skin in the next few months.
Girisan Kariangal, Managing Director of Menarini India said, “I am excited to take on this new responsibility. As we continue to position ourselves for growth in this market, Menarini India’s consolidation plan to focus on Dermatology is testament to Menarini’s commitment to invest and grow our well-diversified Dermatology portfolio in India. Dermatology is a cornerstone of Menarini India’s brand promise to invigorate lives through our products and services. Menarini strives to contribute to advances in dermatology through the development of innovative products that meet the unmet medical needs for control and relief of skin conditions and help patients and consumers lead a better quality of life with confidence. Through our globally acclaimed patient-centered and science-based approach to Dermatology, we envision being the leading global dermatology company in the country in the next 10 years.
We also plan to bring in innovative solutions that help physicians improve treatment outcomes. The roll-out of a pioneering ‘Digital prescription platform’ is one such initiative that helps to ease the process of e-consultation and enhance patient education.”